drugset / Trial / NCT01820715
A Study to Evaluate the Safety of DA-3030 and to Explore the Efficacy for Diabetic Neuropathic Pain
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A multi-centers, placebo-controlled, randomized, double-blinded, pilot clinical trial is designed to evaluate the safety of the DA-3030 injection and to explore the efficacy for Neuropathic pain.
Timeline
- Start
- 2010-06
- Primary completion
- 2013-04
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Leucostim | Unknown | 600 ug | — |